Doximity, Inc. (NYSE:DOCS) Given Consensus Rating of “Moderate Buy” by Analysts

Doximity, Inc. (NYSE:DOCS) has earned a consensus rating of “Moderate Buy” from the nine brokerages that are presently covering the stock, MarketBeat.com reports. Three research analysts have rated the stock with a hold recommendation, four have assigned a buy recommendation and two have issued a strong buy recommendation on the company. The average twelve-month target price among brokerages that have updated their coverage on the stock in the last year is $44.50.

A number of equities analysts have issued reports on DOCS shares. Royal Bank Of Canada upgraded Doximity to a “moderate buy” rating in a report on Thursday, January 8th. The Goldman Sachs Group upgraded Doximity from a “strong sell” rating to a “hold” rating in a report on Friday, January 9th. Needham & Company LLC raised Doximity to a “moderate buy” rating in a research report on Friday, February 6th. Wells Fargo & Company raised Doximity from an “equal weight” rating to an “overweight” rating and set a $55.00 price target for the company in a research report on Tuesday, January 20th. Finally, Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Doximity in a research note on Wednesday, December 24th.

Doximity Price Performance

Shares of DOCS stock opened at $24.47 on Friday. Doximity has a 12-month low of $23.53 and a 12-month high of $76.51. The stock’s fifty day moving average is $36.36. The company has a market capitalization of $4.52 billion, a P/E ratio of 20.39, a price-to-earnings-growth ratio of 1.38 and a beta of 1.39.

About Doximity

Doximity, trading as DOCS, operates a digital professional network and communications platform designed primarily for clinicians. Headquartered in San Francisco, the company connects physicians, nurse practitioners, physician assistants and other healthcare professionals, providing tools that streamline clinical communication, telehealth delivery and access to specialty-specific medical information. Its platform is positioned as a professional hub where clinicians manage their workflows, stay current with medical news and collaborate securely with peers.

The company’s offerings include secure messaging and video telehealth capabilities that enable clinicians to consult with patients and colleagues while protecting patient information.